178 related articles for article (PubMed ID: 28505674)
1. [Novel Adjuvant Therapy for Ocular Melanoma].
Bosch JJ; Heindl LM
Klin Monbl Augenheilkd; 2017 May; 234(5):670-673. PubMed ID: 28505674
[No Abstract] [Full Text] [Related]
2. Calmette-Guerin bacillus treatment of experimental conjunctival malignant melanoma.
Rutgard J; Peyman GA; Frenkel M; Saks S
Arch Ophthalmol; 1977 Dec; 95(12):2214-7. PubMed ID: 588117
[TBL] [Abstract][Full Text] [Related]
3. Antilymphangiogenic therapy to promote transplant survival and to reduce cancer metastasis: what can we learn from the eye?
Hos D; Schlereth SL; Bock F; Heindl LM; Cursiefen C
Semin Cell Dev Biol; 2015 Feb; 38():117-30. PubMed ID: 25460541
[TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint inhibitors in ocular melanomas: contrasting efficacy with cutaneous melanomas.
Hoyek S; Kourie HR; Labaki C; Antoun J
Immunotherapy; 2020 Nov; 12(16):1149-1152. PubMed ID: 33076742
[No Abstract] [Full Text] [Related]
5. [New Therapeutic Approaches in Inflammatory Diseases of the Eye - Targeting Lymphangiogenesis and Cellular Immunity: Research Unit FOR 2240 Presents Itself].
Cursiefen C; Bock F; Clahsen T; Regenfuss B; Reis A; Steven P; Heindl LM; Bosch JJ; Hos D; Eming S; Grajewski R; Heiligenhaus A; Fauser S; Austin J; Langmann T
Klin Monbl Augenheilkd; 2017 May; 234(5):679-685. PubMed ID: 28505676
[No Abstract] [Full Text] [Related]
6. Adjuvant therapy in malignant melanoma.
Kent CJ; Jakobiec FA
Int Ophthalmol Clin; 1997; 37(4):127-34. PubMed ID: 9429936
[No Abstract] [Full Text] [Related]
7. Immunotherapy of uveal melanoma.
Bosch JJ
Dev Ophthalmol; 2012; 49():137-149. PubMed ID: 22042018
[TBL] [Abstract][Full Text] [Related]
8. Proton therapy for the management of uveal melanoma and other ocular tumors.
Mishra KK; Daftari IK
Chin Clin Oncol; 2016 Aug; 5(4):50. PubMed ID: 27558251
[TBL] [Abstract][Full Text] [Related]
9. Translational research in melanoma.
Tsai S; Sabel MS
Surg Oncol Clin N Am; 2008 Apr; 17(2):391-419, ix-x. PubMed ID: 18375359
[TBL] [Abstract][Full Text] [Related]
10. Management of ocular melanoma.
Hungerford JL
Br Med Bull; 1995 Jul; 51(3):694-716. PubMed ID: 7552089
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific immunity in patients with malignant melanoma.
Arlen M; Hollinshead A; Scherrer J
Surg Forum; 1977; 28():168-9. PubMed ID: 83008
[No Abstract] [Full Text] [Related]
12. Uveal melanoma.
Spagnolo F; Caltabiano G; Queirolo P
Cancer Treat Rev; 2012 Aug; 38(5):549-53. PubMed ID: 22270078
[TBL] [Abstract][Full Text] [Related]
13. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
[TBL] [Abstract][Full Text] [Related]
14. Ocular melanoma: relatively rare but requiring respect.
Shields CL; Shields JA
Clin Dermatol; 2009; 27(1):122-33. PubMed ID: 19095158
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant immunotherapy for melanoma and colorectal cancers.
Safa MM; Foon KA
Semin Oncol; 2001 Feb; 28(1):68-92. PubMed ID: 11254868
[TBL] [Abstract][Full Text] [Related]
16. Assessment of immunological techniques in the diagnosis and prognosis of ocular malignant melanoma.
Cochran AJ; Foulds WS; Damato BE; Trope GE; Morrison L; Lee WR
Br J Ophthalmol; 1985 Mar; 69(3):171-6. PubMed ID: 3884037
[TBL] [Abstract][Full Text] [Related]
17. Ocular melanoma.
Char DH
Surg Clin North Am; 2003 Apr; 83(2):253-74, vii. PubMed ID: 12744609
[TBL] [Abstract][Full Text] [Related]
18. Melanoma of the eye: revealing hidden secrets, one at a time.
Shields CL; Kels JG; Shields JA
Clin Dermatol; 2015; 33(2):183-96. PubMed ID: 25704938
[TBL] [Abstract][Full Text] [Related]
19. Ocular Oncology-Primary and Metastatic Malignancies.
Williams BK; Di Nicola M
Med Clin North Am; 2021 May; 105(3):531-550. PubMed ID: 33926645
[TBL] [Abstract][Full Text] [Related]
20. [Immunotherapy of uveal melanoma: vaccination against cancer. Multicenter adjuvant phase 3 vaccination study using dendritic cells laden with tumor RNA for large newly diagnosed uveal melanoma].
Schuler-Thurner B; Bartz-Schmidt KU; Bornfeld N; Cursiefen C; Fuisting B; Grisanti S; Heindl LM; Holbach L; Keserü M; Knorr H; Koch K; Kruse F; Meiller R; Metz C; Meyer-ter-Vehn T; Much M; Reinsberg M; Schliep S; Seitz B; Schuler G; Süsskind D; Viestenz A; Wagenfeld L; Zeschnigk M
Ophthalmologe; 2015 Dec; 112(12):1017-21. PubMed ID: 26602097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
